Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

for
Leukemia, HOX Gene
Location: Houston TX, New York NY
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 12+

Code: NCT06229912

Phase2, Recruiting

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

for
Gastrointestinal Neoplasms
Location: Houston TX, San Antonio TX, Aurora CO, Madison WI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06885034

Phase1, Phase2, Recruiting

A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

for
Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05929612

Phase2, Recruiting

Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

for
Lymphoma
Location: Houston TX, San Antonio TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05676450

Recruiting

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

for
Advanced Bladder Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06434350

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

for
Diabetes, Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06759701

Early_phase1, Recruiting

Frame Support Study

for
Fertility Issues, Emotional Stress
Location: Houston TX
Sponsor: Inception Fertility Research Institute, LLC

Sex: Female

Age: 22 - 44

Code: NCT07083700

Recruiting

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

for
Venous Thromboembolism (VTE)
Location: Bellaire TX, Houston TX, San Antonio TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07015905

Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

for
Heart Failure
Location: Tomball TX, McKinney TX, Brownsville TX, Lincoln NE,
Sponsor: Pfizer

Sex: All

Age: 18 - 70+

Code: NCT06991257

Phase2, Recruiting

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

for
Monoclonal Gammopathy of Undetermined Significance,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT02726750

Recruiting

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Houston TX, Westwood KS, Sarasota FL, Milwaukee WI,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT05875168

Phase1, Phase2, Recruiting

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

for
Dry Age-related Macular Degeneration, Geographic Atrophy
Location: The Woodlands TX, Lemont IL, Huntington Beach CA,
Sponsor: Regenerative Patch Technologies, LLC

Sex: All

Age: 55 - 70+

Code: NCT06557460

Phase2, Recruiting

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

for
Metabolic Associated Fatty Liver Disease,
Location: Bellaire TX, San Antonio TX, Miami FL, Columbus OH
Sponsor: Foundation for the National Institutes of Health

Sex: All

Age: 18 - 70+

Code: NCT07122700

Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for
Colorectal Cancer
Location: Houston TX, Austin TX, Fort Worth TX, Grapevine TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07023289

Phase2, Recruiting

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

for
Chronic Low-back Pain, Vertebrogenic Pain Syndrome
Location: Houston TX, New Orleans LA, Jasper GA, Lexington KY,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT06827262

Recruiting

Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies

for
Lymphodepleting Chemotherapy, Myeloid Malignancies
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06383572

Phase1, Phase2, Recruiting

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

for
Pulmonary Hemorrhage, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05053867

Phase3, Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Houston TX, St Louis MO, Tampa FL, Phoenix AZ,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase1, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Squamous Non-Small Cell Lung Cancer
Location: Houston TX, Palestine TX, Austin TX, Lincoln NE,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07005102

Phase2, Phase3, Recruiting

Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission

for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05010772

Phase1, Recruiting